Stock Events

Stock Events

Syros Pharmaceuticals (SYRS) Q2 2024 Earnings

14MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-2.18

-1.49

-0.79

-0.1

Details

Expected EPS

-0.84718

Actual EPS

-0.1

Surprise EPS

0.75

Surprise Percent

+88.2%

Description

Syros Pharmaceuticals (SYRS) has reported earnings of -0.1 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.